On 28 and 29 January, a seminar entitled Clinical Applications of Nanotechnologies in the Field of Cancer will take place in Montpellier. At this international meeting, researchers, doctors, and industry representatives currently working on different projects throughout this geographical area will come together both to report their latest results and to move forward on new joint initiatives. The seminar is being organized by the Institute for Bioengineering of Catalonia (IBEC), the Cancéropôle GSO (Toulouse, Grand Sud-Ouest), and the Cancéropôle CLARA (Lyon, Rhône Alpes-Auvergne), with the support of InNaBioSanté.
The application of nanotechnology to the diagnosis and treatment of cancer opens the door to significant breakthroughs in the management of neoplastic disease. The control of biomolecular materials at the nano-scale has made it possible to create miniature devices that can provide much faster and more precise ways of diagnosing and monitoring cancer than those currently available. Nanotechnology will also be used to develop personalized therapies associated with fewer side effects.
Efficient transfer of the power of nanotechnology from the laboratory to clinical applications depends on close collaboration between scientists and the authorities responsible for regulating and approving the use of new medical products and these agencies will also play an active role in the upcoming seminar.
The aim of this event is to foster collaboration between researchers and specialists in the fields of nanotechnology and cancer and to strengthen the links and relationships between researchers working throughout Catalonia, Toulouse-Montpellier-Bordeaux and Grenoble-Lyon.
